Americans for Fair Treatment, Inc. – Trademark Portfolio
Entity Type: 03
Americans for Fair Treatment, Inc. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 1 filings in this category. The portfolio also extends into Class 45 (Legal & Security Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AFFT AMERICANS FOR FAIR TREATMENT. The owner is based in Oklahoma City, OK.
1200 NW 63rd St., Suite 5000
Oklahoma City, OK 73116
Showing of trademarks Trademarks
Trademark Classifications
Americans for Fair Treatment, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Americans for Fair Treatment, Inc. have?
Americans for Fair Treatment, Inc. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Americans for Fair Treatment, Inc. file in?
Americans for Fair Treatment, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 45 (Legal & Security Services). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Americans for Fair Treatment, Inc.'s most well-known trademarks?
Americans for Fair Treatment, Inc.'s registered trademark portfolio includes well-known marks such as AFFT AMERICANS FOR FAIR TREATMENT. These are among 1 currently registered trademark in the portfolio.
What is Americans for Fair Treatment, Inc.'s trademark registration success rate?
Americans for Fair Treatment, Inc. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.